Angiographic findings and procedural details
| Angiographic findings and procedural details | Early coronary intervention group (n=81) | Delayed coronary intervention group (n=81) | P value |
| Single-vessel CAD | 29 (35.8) | 33 (40.7) | 0.628 |
| Multivessel CAD | 52 (64.2) | 48 (59.3) | 0.628 |
| Target vessel revascularisation (%) | |||
| LAD | 39 (48.2) | 38 (46.9) | 0.500 |
| LCX | 5 (6.2) | 10 (12.4) | 0.279 |
| RCA | 36 (44.4) | 33 (40.7) | 0.751 |
| Left main | 1 (1.2) | 0 (0) | 0.500 |
| Culprit vessel PCI (%) | 66 (81.5) | 65 (80.2) | 0.500 |
| Multivessel PCI (%) | 8 (9.9) | 8 (9.9) | 0.603 |
| Medical treatment or CABG (%) | 7 (8.6) | 8 (9.9) | 0.500 |
| Procedural details | |||
| POBA | 5 (6.8) | 6 (8.2) | 0.765 |
| Thrombus aspiration | 9 (12.2) | 3 (4.1) | 0.129 |
| Bare-metal stent | 10 (13.5) | 2 (2.7) | 0.031 |
| Drug-eluting stent | 59 (79.7) | 65 (89.0) | 0.173 |
| Lesion length (mm), mean±SD | 27.0±12.2 | 24.8±9.6 | 0.253 |
| Vessel diameter (mm), mean±SD | 3.0±0.5 | 2.9±0.4 | 0.480 |
| Number of stents used per patient, mean±SD | 1.2±0.5 | 1.2±0.5 | 0.898 |
| Pre-PCI TIMI flow 0–1 (%) | 9 (11.1) | 4 (4.9) | 0.247 |
| Pre-PCI TIMI flow 2–3 (%) | 72 (88.8) | 77 (95.0) | 0.247 |
| Post-PCI TIMI flow 0–1 (%) | 3 (3.7) | 1 (1.2) | 0.620 |
| Post-PCI TIMI flow 2–3 (%) | 71 (95.9) | 72 (98.6) | 0.500 |
| Low molecular weight heparin (%) | 66 (81.5) | 73 (90.1) | 0.176 |
| Glycoprotein IIb/IIIa inhibitor used (%) | 15 (18.5) | 10 (12.5) | 0.385 |
CABG, coronary artery bypass graft; CAD, coronary artery disease; LAD, left anterior descending artery;LCX, left circumflex artery;PCI, percutaneous coronary intervention; POBA, plain old balloon angioplasty;RCA, right coronary artery; TIMI, Thrombolysis in Myocardial Infarction.